(Q38151588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Daniele Santini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Stefano Cascinu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Matteo Santoni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Consuelo Amantini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Luciano Burattini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Giorgio Santoni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

18 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

2772-2777

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24114790%20AND%20SRC:MED&resulttype=core&format=json

Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma

27 February 2020

cites work

1 reference

Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).

21 January 2018

1 reference

VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.

21 January 2018

1 reference

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

Mammalian target of rapamycin inhibitors in renal cell carcinoma: current status and future applications

21 January 2018

1 reference

Present and future of tyrosine kinase inhibitors in renal cell carcinoma: analysis of hematologic toxicity.

21 January 2018

1 reference

Regulation of immune responses by mTOR.

21 January 2018

1 reference

Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay.

21 January 2018

1 reference

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors

21 January 2018

1 reference

Neutrophils in the activation and regulation of innate and adaptive immunity

21 January 2018

1 reference

Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression

21 January 2018

1 reference

Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model.

21 January 2018

1 reference

Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma

21 January 2018

1 reference

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

21 January 2018

1 reference

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

21 January 2018

1 reference

Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients

21 January 2018

1 reference

Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma

21 January 2018

1 reference

Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array.

21 January 2018

1 reference

Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages

21 January 2018

1 reference

Sorafenib induces autophagy and suppresses activation of human macrophage

21 January 2018

1 reference

Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.

21 January 2018

1 reference

The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages

21 January 2018

1 reference

Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained

21 January 2018

1 reference

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

21 January 2018

1 reference

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy

21 January 2018

1 reference

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

21 January 2018

1 reference

Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes

21 January 2018

1 reference

Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging.

21 January 2018

1 reference

The kinase inhibitors sunitinib and sorafenib differentially affect NK cell antitumor reactivity in vitro

21 January 2018

1 reference

Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2.

21 January 2018

1 reference

T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6.

21 January 2018

1 reference

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

21 January 2018

1 reference

Current concepts of tumor-infiltrating lymphocytes in human malignancies

21 January 2018

1 reference

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation

21 January 2018

1 reference

Sunitinib impairs the proliferation and function of human peripheral T cell and prevents T-cell-mediated immune response in mice.

21 January 2018

1 reference

LY294002 and rapamycin co-operate to inhibit T-cell proliferation

21 January 2018

1 reference

The effect of sunitinib on immune subsets in metastatic clear cell renal cancer.

21 January 2018

1 reference

A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patients

21 January 2018

1 reference

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.

21 January 2018

1 reference

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

21 January 2018

1 reference